Premier, Long Grove join forces to increase supply of norepinephrine IV bags
Premier, through its ProvideGx program, has entered into an agreement with Long Grove Pharmaceuticals to supply norepinephrine IV bags, helping to meet immediate and long-term supply needs for a therapy to treat patients with low blood pressure and heart failure.
Norepinephrine IV bags have experienced ongoing product availability issues over the past five years as demand has outpaced supply. With few suppliers in the market, the Premier and Long Grove Pharmaceuticals collaboration supports supplier diversification and a more stable product supply by increasing the availability of adequate safety stock on a long-term basis.
“We’re pleased to offer Norepinephrine Premix IV bags through the ProvideGx supply channel,” said Peter Karas, chief commercial officer at Long Grove Pharmaceuticals. “This joint effort with Premier, coupled with our rapidly amplified improvements on a variety of complex generic drug reformulations, will help to simplify processes, increase efficiency and support reliable product supply for a critical drug.”
[Read more: Long Grove gets FDA OK for generic Radicava]
“Our collaboration with Long Grove Pharmaceuticals is yet another step forward to help ensure a more robust supply environment and the continued availability and affordability of high-quality therapies for healthcare providers and patients,” said Bruce Radcliff, senior vice president of supply chain services at Premier. “Together, we are enabling a more diversified pharmaceutical market designed to create sustainable supply of a drug product that is vital for patient care in the United States.”
Guided by health systems with more than 1,600 hospitals across the nation, Premier’s ProvideGx program creates long-term committed buying contracts with participating manufacturers—creating a steady demand signal and guaranteed customer base for manufacturers in exchange for their production of generics in shortage, which helps maintain safety stocks and more diversified supply sources. ProvideGx offers members access to more than 150 drugs that are or have been recently designated as shortage drugs. The program has successfully helped resolve 15 drug shortages, resulting in their official delisting from the FDA’s shortage list.
[Read more: Long Grove launches premix norepinephrine]